ovarian-cancer

Documents about ovarian-cancer

• Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy#866782ClinicalTrials.gov
• [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications#855742ClinicalTrials.gov
• The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI#873377ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma#895875ClinicalTrials.gov
• Proteomic profiling and molecular reclassification of high-grade serous ovarian cancer identifies prognostic subtypes and immunotherapy biomarkers.#125390NCBI PubMed Central
• Multi-scale evidence chain: Linking environmental BPA exposure to ovarian cancer through integrated omics and experimental models.#157921NCBI PubMed Central
• XGBoost-Cox modeling with SHAP analysis for survival prediction in ovarian cancer patients: a retrospective cohort study.#159789NCBI PubMed Central
• Applications of Large Language Models in Ovarian Cancer Management: Protocol for a Systematic Review and Meta-Analysis.#360879NCBI PubMed Central
• Dual-Mechanism Aptamer-Drug Complex Overcomes Paclitaxel Resistance in Ovarian Cancer via Structural Constraint and Telomerase Inhibition.#371427NCBI PubMed Central
• Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer#676837HAL (France)
• Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies#890548ClinicalTrials.gov
• Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)#854061ClinicalTrials.gov
• A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies#287543ClinicalTrials.gov
• ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients#802559ClinicalTrials.gov
• A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors#829476ClinicalTrials.gov
• DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study#904331ClinicalTrials.gov
• Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer#835343ClinicalTrials.gov
• Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies#803666ClinicalTrials.gov
• A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors#863287ClinicalTrials.gov
• A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours#870789ClinicalTrials.gov
• Clinical utility of diagnosing Lynch syndrome in gynecologic oncology: a joint statement from four Japanese academic societies#477041OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin#884790ClinicalTrials.gov
• Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)#852205ClinicalTrials.gov
• A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen#853191ClinicalTrials.gov
• A Phase 1 Study of [225Ac]-FPI-1434 Injection#859603ClinicalTrials.gov
• Exploring the experiences, challenges, and coping strategies of caregivers of women with Ovarian Cancer: A scoping review.#150293NCBI PubMed Central
• Health economic evaluation of Mirvetuximab soravtansine for the treatment of FRα-positive, platinum resistant ovarian cancer in Germany.#221049NCBI PubMed Central
• Deciphering the potential pathogenic mechanisms of 3-BHA in ovarian cancer through integrated bioinformatics and machine learning strategies.#297264NCBI PubMed Central
• 580 A regional audit & feedback intervention to improve quality of care in ovarian cancer treatment. The easy-net experience#823187IRIS
• Long-acting G-CSF for Febrile Neutropenia#882805ClinicalTrials.gov
• Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma#851901ClinicalTrials.gov
• Differences in first-line chemosensitivity assessed by ELIMination rate constant K in advanced serous ovarian cancer: evidence from Western and Japanese Trials in a Gynecologic Cancer InterGroup meta-analysis#433343HAL (France)
• Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors#904431ClinicalTrials.gov
• Identifying and Caring for Individuals With Inherited Cancer Syndrome#866432ClinicalTrials.gov
• Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1#888097ClinicalTrials.gov
• Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer#346989ClinicalTrials.gov
• A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors#842594ClinicalTrials.gov
• Translating Liquid Biopsy into Practice- The Promise and Challenges of Circulating Tumor Cells in Ovarian and Lung Cancer Management.#4398NCBI PubMed Central
• Different Immune Cells Modified With Chimeric Antigen Receptors Are Being Applied to Ovarian Cancer: Which Is the Most Effective?#151474NCBI PubMed Central
• Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC#201595ClinicalTrials.gov
• Machine Learning Models for Predicting Liver Metastasis at Diagnosis and Overall Survival in Ovarian Cancer: A SEER-Based Study.#244278NCBI PubMed Central
• Patient Selection Metrics and Efficacy of Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Retrospective Analysis.#330793NCBI PubMed Central
• Cigarette smoking and the risk of ovarian cancer in the Japanese population : Findings from the Japanese Collaborate Cohort study#384029CiNii
• Identifying patients with apparent early-stage ovarian cancer at very low risk of lymph node metastasis: a multicenter preoperative prediction model#433360HAL (France)
• ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients#844410ClinicalTrials.gov
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC#894734ClinicalTrials.gov
• A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies#812777ClinicalTrials.gov
• Integrative proteomics reveals MSH6 to modulate PARP inhibitor sensitivity in <i>BRCA1/2</i>-proficient ovarian cancer#636999PLOS
• COsegregation of VARiants in Panel of Genes#899208ClinicalTrials.gov
• Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer#833591ClinicalTrials.gov